Cargando…

COVID-19 Vaccination Safety Profiles in Patients with Solid Tumour Cancers: Comment

Detalles Bibliográficos
Autores principales:	Kleebayoon, A., Wiwanitkit, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal College of Radiologists. Published by Elsevier Ltd. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159660/ https://www.ncbi.nlm.nih.gov/pubmed/37169672 http://dx.doi.org/10.1016/j.clon.2023.04.008

Ejemplares similares

Immunogenicity, effectiveness and safety of COVID-19 vaccine in older adults living in nursing homes: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Determinants of the Attitude to COVID-19 Vaccine
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine-associated autoimmune disorders: Comments
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute myocarditis after administration of COVID-19 vaccine: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Assessment of psychological distress & COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination and idiopathic sudden sensorineural hearing loss: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Factors affecting intention of COVID‐19 preventive behaviours including vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

“Acute psychosis induced by mRNA-based COVID-19 vaccine in adolescents: A pediatric case report”: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccines and retinal microvasculature: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment: Post COVID-19 Vaccination Encephalitis as a Cause of Subacute Progressive Dementia: A Case Report and Literature Review
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on the effectiveness of four SARS-COV-2 vaccines
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination uptake in people with epilepsy: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Acute disseminated encephalomyelitis and COVID-19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Side Effects Comparison of Coronavirus Vaccines Among Healthcare Workers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine type and Guillain-Barré syndrome: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Hesitancy toward vaccination against COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Willingness of college students to receive COVID-19 heterologous vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on the evaluation of patients with COVID-19 vaccine side effects
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Vaccination rates, perceptions, and information sources in inflammatory arthritis: Comment on the article by Lyon et al
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Ocular sparganosis: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence: Clinical Course of Adverse Effects after COVID-19 Vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on Self-Sampling Methodology Impression for Cervical Cancer Screening
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on adverse conditions of COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccines and increased blood pressure
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Post-Vaccine SARS-CoV-2 Reinfection and Associated Factors Among Health Care Providers: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccination status and related process of care outcomes
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

COVID-19 vaccine immune response and plasma cell dyscrasia
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

THE LANGUAGE MODELS IN HEALTHCARE AND THE ROLE OF CHATGPT: COMMENTS
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Covid‐19 vaccination landscape in Malta through social media: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Intention to receive COVID-19 vaccine and its health belief model (HBM)-based predictors: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Comment on “How may ChatGPT impact medical teaching?”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Humoral response to COVID-19 vaccination and maintenance hemodialysis: Correspondence
por: Mungmunpuntipantip, Rujititka, et al.
Publicado: (2023)

Adverse effects and antibody responses following homologous and heterologous COVID19 prime-boost vaccinations
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Letter to the Editor Regarding “The Effect of COVID-19 Vaccines on Stroke Outcomes: A Single-Center Study”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cglokkctko3ppq4k9hsbbmmu61